Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04496518 · ClinicalTrials.gov registry record
Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)
A clinical trial of Ventricular Tachycardia, sponsored by Medtronic.
- Active
- Registry status
- 2,200
- Enrollment target
- 20
- Study locations
NCT04496518: Active study of Ventricular Tachycardia, sponsored by Medtronic.
NCT04496518 is a study of Ventricular Tachycardia that is active but no longer recruiting, run by Medtronic. The registered enrollment target is 2,200 participants, above the 210-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (948% higher). The trial reports 20 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04496518, a study of Ventricular Tachycardia, is active but no longer recruiting, sponsored by Medtronic.
- ACTIVE NOT RECRUITING
- Registry status
- 2,200 participants
- Enrollment target
- 20
- Study locations
Study Summary
Medtronic is sponsoring the Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS) to further confirm safety and effectiveness of ventricular iATP therapy in routine clinical practice, following commercial release of iATP-capable devices. The iATP PAS is conducted within Medtronic's Product Surveillance Registry platform (NCT01524276).
Primary Outcome
Demonstrating success rate of iATP
Conditions Studied
Interventions
- DEVICE Intrinsic Antitachycardia Pacing (iATP) Therapy
Study Locations (20)
Florida
- Heart Rhythm Solutions - Hollywood
- Baptist Health - Jacksonville
- Cardiovascular Institute of Northwest Florida - Panama City
- Heart & Vascular Institute of Florida - Safety Harbor
- Heart Rhythm Consultants P.A. (Sarasota Memorial Research) - Sarasota
California
- Chula Vista Cardiac Center - Chula Vista
- Cardiovascular Consultants Medical Group (Van Nuys CA) - Van Nuys
- Cardiology Associates Medical Group - Ventura
Colorado
- Colorado Springs Cardiology - Colorado Springs
- Denver Heart - Denver
- Colorado Heart and Vascular, PC - Lakewood
Connecticut
- Hartford Hospital - Hartford
- Yale New Haven Hospital - New Haven
Arizona
- Southwest EP - Chandler
Arkansas
- Saint Vincent Heart Clinic Arkansas - Little Rock
Indiana
- Deaconess Specialty Physicians - Evansville
Iowa
- Iowa Heart Center (West Des Moines IA) - Des Moines
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,200 participants |
| Start Date | 2020-08-01 |
| Est. Completion | 2028-01-31 |
What the registry record for NCT04496518 still lists
NCT04496518 is an observational study that tracks outcomes without assigning an intervention. Its 2,200 participants enrollment target places it among the larger protocols in the corpus, above the 210-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (948% higher).
The record links to 1 condition, with Ventricular Tachycardia appearing as the primary indexed condition, and to 1 intervention - of which Intrinsic Antitachycardia Pacing (iATP) Therapy is the first listed.
NCT04496518 names 20 study sites across 11 states, led by Florida, California, Colorado.
Frequently Asked Questions
What is clinical trial NCT04496518 about?
NCT04496518 is a clinical study titled "Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)". Medtronic is sponsoring the Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS) to further confirm safety and effectiveness of ventricular iATP therapy in routine clinical practice, following commercial release of iATP-capable devices. The iATP PAS is conducted within Medtronic's Produc...
What is the current status of trial NCT04496518?
This trial is currently active not recruiting. The enrollment target is 2,200 participants. The study started on 2020-08-01. Estimated completion is 2028-01-31.
What conditions does trial NCT04496518 study?
This clinical trial studies the following conditions: Ventricular Tachycardia.
What interventions are being tested in trial NCT04496518?
The interventions under investigation include: Intrinsic Antitachycardia Pacing (iATP) Therapy (DEVICE).
Who is sponsoring clinical trial NCT04496518?
This trial is sponsored by Medtronic, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04496518 being conducted?
This trial has 20 study locations across Arizona, Arkansas, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventricular Tachycardia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04496518's enrollment target sits among peer trials
2,200 1st of 28 higher than 28 of 28 other Ventricular Tachycardia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ventricular Tachycardia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ventricular Tachycardia Mechanisms
RECRUITING · NA
-
Randomized Assessment of TcMS for VT Storm
RECRUITING · NA
-
Cardiac Radioablation for VT
RECRUITING · NA
-
Defining the Risk of Ventricular Tachycardia in Genetic Forms of Early-onset Atrial Fibrillation
RECRUITING
-
Ablation-Index Guided Scar-Mediated Ventricular Tachycardia Ablation in Patients With Ischemic Cardiomyopathy
RECRUITING · NA
-
Pulsed Field Ablation for Post-Infarction Ventricular Tachycardia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05654207 · 2,200 participants · NA
WeCare: A System of Care for Black Youth
- NCT06144554 · 2,200 participants
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
- NCT06526988 · 2,200 participants · NA
Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure
- NCT06682650 · 2,200 participants · NA
Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI